TCX Skincare Colloidal Oatmeal 2 g/100g Cream, 59 g
by Theraceutix, LLC · 59 g in 1 JAR (49449-100-01)
NDC 49449-0100-01
🏷️ FDA NDC (as labeled)
49449-100-01
billing pads the product segment with a zero
This package
Contains59 g
Pack sizes2 compare ↓
Also comes in:
9 g 49449-0100-02
OTC
On market
Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
49449-100-01
Product NDC
49449-100
11-digit billing NDC
49449010001
RxCUI
1189915
UNII
8PI54V663Y
Application #
M016
SPL Set ID
c3be950b-28cf-47c2-9570-ebd46e43b1ba
Established class (EPC)
Non-Standardized Food Allergenic Extract; Non-Standardized Plant Allergenic Extract
Physiologic effect
Increased Histamine Release; Cell-mediated Immunity
Chemical class
Allergens; Dietary Proteins; Plant Proteins
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2012-05-17
Route
TOPICAL
Dosage form
CREAM
Substance
OATMEAL
Why two NDCs?
The FDA registers this code as 49449-100-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 49449-0100-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the Non-Standardized Food Allergenic Extract class.
Pharmacologic class
Non-Standardized Food Allergenic Extract, Non-Standardized Plant Allergenic Extract
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerTheraceutix, LLC
FDA applicationM016 (OTC MONOGRAPH DRUG)
Labeler code49449
First marketedMay 2012
Product typeHuman Otc Drug
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
🧪 What is this product?
TCX Skincare Colloidal Oatmeal is a topical cream containing 2 grams of oatmeal per 100 grams. This is an over-the-counter monograph product marketed under FDA regulations for OTC drugs in its category. Colloidal oatmeal is typically used in skin care products for its soothing properties and is commonly applied to the skin to help calm irritation and itching.
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about Colloidal Oatmeal?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size:
9 g
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Cetaphil Eczema Rapid Relief Cream 2 g/100g 00299-4144-00 | Galderma | 227 g | — | — | FDA listed | — |
| TriDerma Eczema Fast Healing Face Body 2 g/100g 10738-0154-65 | Genuine | 170 g | — | — | FDA listed | — |
| Gold Bond Medicated eczema relief 20 mg/g 41167-0567-01 | Chattem, | 155 g | — | — | FDA listed | — |
| Gold Bond Eczema Relief Medicated Hand Cream 2 g/100g 41167-0668-00 | Chattem, | 85 g | — | — | FDA listed | — |
| Gold Bond Eczema Relief Medicated Skin Protectant Cream 2 g/100g 41167-0669-01 | Chattem, | 121 g | — | — | FDA listed | — |
| TCX Skincare 2 g/100gthis 49449-0100-01 | Theraceutix, | 59 g | — | — | FDA listed | — |
| Nizoral Eczema Relief Cream 2 g/100g 55505-0223-33 | Kramer | 1 bottle | — | — | FDA listed | — |
| Extra Strength Body 2 g/100mL 61328-0119-28 | Skinfix, | 236 ml | — | — | FDA listed | — |
| Eczema Intensive Daily Relief Body 2 g/100g 61328-0210-00 | Skinfix, | 177 g | — | — | FDA listed | — |
| The Indigo Calming 20 mg/mL 69417-0140-03 | TATCHA | 1 jar | — | — | Discontinued | — |
| CLn Body Moisturizer 2 g/100g 69530-0858-01 | TopMD | 30 g | — | — | FDA listed | — |
| Aveeno Eczema Therapy Rescue Relief Treatment 20 mg/mL 69968-0802-01 | Kenvue | 14 ml | — | — | FDA listed | — |
| Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream 20 mg/g 69968-1003-02 | Kenvue | 44 g | — | — | FDA listed | — |
| OKeeffes Skin Repair Body Cream Eczema Relief 2 g/100g 71564-0010-98 | The | 198 g | — | — | FDA listed | — |
| Eczema Reliegf Skin Protectant EQB 2 g/100g 79903-0209-08 | Walmart | 226 g | — | — | FDA listed | — |
| Dermoia Manuka Honey Eczema 20 mg/mL 83524-0607-00 | TREASUREWISE | 120 ml | — | — | FDA listed | — |
| Gold Bond Medicated eczema relief 20 mg/g 84714-0567-01 | Gold | 155 g | — | — | FDA listed | — |
| Gold Bond Eczema Relief Medicated Hand Cream 2 g/100g 84714-0668-00 | Gold | 85 g | — | — | FDA listed | — |
| Gold Bond Eczema Relief Medicated Skin Protectant Cream 2 g/100g 84714-0669-01 | Gold | 121 g | — | — | FDA listed | — |
| Soteri Skin Baby Eczema Relief Cream 2 g/100mL 85265-0104-01 | Soteri | 1 bottle | — | — | FDA listed | — |
| Everyday Eczema 2 g/100g 54136-0181-25 | Better | 244 g | — | — | FDA listed | — |
| Evereden Intensive Eczema Balm 2 g/100g 72113-0109-21 | Eden | 1 jar | — | — | FDA listed | — |
| Calming Itch and Irritation 2 g/100g 54136-0183-24 | Better | 239 g | — | — | FDA listed | — |
| Eczema Skin Relief Cream 2 g/100g 51316-0860-01 | CVS | 227 g | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2012
On the market since
May 2012
📍
2026
Currently FDA-listed
14 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for TCX Skincare (this brand).
Top reported reactions
Age at onset
Reporter sex
Male · 50%
Female · 50%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 49449-0100-01 You're viewing this | 59 g in 1 JAR (49449-100-01) | 2012-05-17 | Active |
| 49449-0100-02 | 9 g in 1 JAR (49449-100-02) | 2012-05-17 | Active |
You're viewing the largest of 2 pack sizes for this product.
Pack size FAQ
What quantity is in NDC 49449-0100-01?
NDC 49449-0100-01 contains 59 g — 59 g in 1 jar.
What is the difference between NDC 49449-0100-01 and NDC 49449-0100-02?
Both are TCX Skincare Colloidal Oatmeal 2 g/100g Cream — the drug itself is identical. NDC 49449-0100-01 is the 59 g package, while NDC 49449-0100-02 is the 9 g package.
What NDC number is used to bill for this package of TCX Skincare Colloidal Oatmeal 2 g/100g Cream?
Bill NDC 49449-0100-01 — the 11-digit billing format is 49449010001. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
🧭 About this NDC listing & data coverage
Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 49449-100-01, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 49449-0100-01, written without dashes as 49449010001. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 49449-0100-01, the first segment (49449) is the labeler code FDA assigned to Theraceutix, LLC; the middle segment (0100) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Theraceutix, LLC. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 9 g (49449-0100-02). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Theraceutix, LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Uses • Temporarily protects and helps relieve minor skin irritation and itching due to dry skin and eczema
⏱️ Dosage and Administration ▾
Directions • Apply to affected areas of skin twice daily
⚠️ Warnings ▾
Warnings • For external use only Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. When using this product: • Do not get into eyes • Stop use and ask doctor if condition worsens
🧪 Active Ingredient ▾
Active Ingredient Colloidal Oatmeal 2%
🧪 Inactive Ingredients ▾
Inactive Ingredients Caprylic/Capric Triglyceride, Carbomer, Cetyl Alcohol, Cetyl Palmitate, Dimethicone, DMDM Hydantoin, Glycerin, Glyceryl Stearate, Iodopropynyl Butylcarbamate, Mineral Oil, Octyldodecanol, PEG-40 Stearate, Phenoxy Ethanol, Sodium Hydroxide, Water
🎯 Purpose ▾
Purpose Skin protectant
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.